)
)
ReproCELL Incorporated Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from ReproCELL Incorporated
Access all reports
ReproCELL Incorporated is a biotechnology company focused on advancing stem cell research and drug discovery. The company specializes in providing services and products for stem cell research, including iPSC-derived cell lines, media, and other culture reagents. It also offers predictive drug discovery services utilizing human tissues. ReproCELL's offerings support both preclinical and clinical research, with services tailored to meet regulatory standards across various global markets. Its portfolio includes advanced solutions for gene editing, stem cell therapy, and 3D cell culture systems, which cater to a wide range of scientific and medical applications. The company is headquartered in Yokohama, Kanagawa, Japan, and its shares are listed on the Tokyo Stock Exchange.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
4978
Country
🇯🇵 Japan